Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer

2549.6000 -29.50 (-1.14%)

NSE Sep 15, 2025 15:31 PM

25.62% Fall from 52W High

Volume: 24,309

Ajanta Pharma Ltd.

04 Nov 2022

2549.60

-1.14%

Ajanta Pharma (HOLD): No respite from margin pressure; cut to HOLD

Hold: Ajanta Pharma Ltd.

BOB Capital Markets Ltd.

Q2 revenue growth muted at 6% YoY as lower Africa/US sales offset a strong uptick in India/Asia business

Ajanta Pharma Ltd. has an average target of 3022.00 from 5 brokers.